Dr. Reddy's Laboratories (RDY) Short Interest Ratio & Short Volume → Urgent Alert: Is the U.S. Implementing a Digital Dollar? (From Gold Gate Capital) (Ad) Free RDY Stock Alerts $73.47 -0.95 (-1.28%) (As of 04/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Dr. Reddy's Laboratories Short Interest DataCurrent Short Volume751,000 sharesPrevious Short Volume625,800 sharesChange Vs. Previous Month+20.01%Dollar Volume Sold Short$53.45 millionShort Interest Ratio / Days to Cover3.9Last Record DateApril 15, 2024Outstanding Shares166,880,000 sharesPercentage of Shares Shorted0.45%Today's Trading Volume181,960 sharesAverage Trading Volume195,432 sharesToday's Volume Vs. Average93% Short Selling Dr. Reddy's Laboratories ? Sign up to receive the latest short interest report for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRDY Short Interest Over TimeRDY Days to Cover Over TimeRDY Percentage of Float Shorted Over Time Ad PharmaStocksTodayNYSE Spotlight & A Soaring Biotech Breakthrough You Need to SeeThe CEO of a groundbreaking biotech firm we’ve been closely following made headlines with a stunning appearance on the NY Stock Exchange floor, unveiling news that's too big to ignore. But here’s why this matters to you: in the world of investing, timing is everything. Get instant access to our exclusive report Dr. Reddy's Laboratories Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024751,000 shares $53.45 million +20.0%N/A3.9 $71.17 3/31/2024625,800 shares $45.90 million -11.8%N/A3.2 $73.35 3/15/2024709,300 shares $53.36 million +9.4%N/A3.5 $75.23 2/29/2024648,100 shares $49.79 million -6.6%N/A2.8 $76.83 2/15/2024693,500 shares $52.03 million -9.7%N/A2.9 $75.02 1/31/2024768,000 shares $55.35 million +4.3%N/A3.2 $72.08 Get the Latest News and Ratings for RDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024736,100 shares $51.07 million -13.4%N/A2.9 $69.38 12/31/2023849,500 shares $59.11 million -22.8%N/A3.3 $69.58 12/15/20231,100,000 shares $73.29 million -5.2%N/A4.1 $66.63 11/30/20231,160,000 shares $81.08 million +9.4%N/A4.4 $69.90 11/15/20231,060,000 shares $69.64 million -16.5%N/A4.3 $65.70 10/31/20231,270,000 shares $82.72 million +4.1%N/A4.3 $65.13 10/15/20231,220,000 shares $81.04 million +10.9%N/A4.1 $66.43 9/30/20231,100,000 shares $73.56 million -36.8%N/A3.8 $66.87 9/15/20231,740,000 shares $121.54 million +8.1%N/A6.3 $69.85 8/31/20231,610,000 shares $109.44 million -6.9%N/A6 $67.98 8/15/20231,730,000 shares $122.95 million +32.1%1.0%6.6 $71.07 7/31/20231,310,000 shares $89.97 million -4.4%0.8%5.4 $68.68 7/15/20231,370,000 shares $84.80 million -23.5%0.8%5.9 $61.90 6/30/20231,790,000 shares $112.99 million -4.3%N/A7.5 $63.13 6/15/20231,870,000 shares $111.07 million -1.1%N/A7.6 $59.40 5/31/20231,890,000 shares $104.31 million +3.3%N/A7.6 $55.19 5/15/20231,830,000 shares $101.20 million -3.7%N/A7.6 $55.30 4/30/20231,900,000 shares $114.87 million +7.3%N/A9 $60.46 4/15/20231,770,000 shares $106.36 million No ChangeN/A8.8 $60.09 3/31/20231,770,000 shares $100.77 million +29.2%N/A9.1 $56.93 3/15/20231,370,000 shares $73.13 million +1.5%N/A7.5 $53.38 2/28/20231,350,000 shares $70.54 million +6.3%N/A7.9 $52.25 2/15/20231,270,000 shares $70.09 million +7.6%N/A6.9 $55.19 1/31/20231,180,000 shares $63.48 million -12.6%N/A5.9 $53.80 1/15/20231,350,000 shares $72.36 million +16.4%N/A6.3 $53.60 12/30/20221,160,000 shares $60.03 million No ChangeN/A5.5 $51.75 12/15/20221,160,000 shares $62.08 million -8.7%N/A5.3 $53.52 11/30/20221,270,000 shares $71.51 million -2.3%N/A5.3 $56.31 11/15/20221,300,000 shares $71.54 million -19.8%N/A5.6 $55.03 10/31/20221,620,000 shares $87.98 million +3.9%N/A6.9 $54.31 10/15/20221,560,000 shares $80.71 million -12.9%N/A7.3 $51.74 9/30/20221,790,000 shares $93.69 million +5.9%N/A8 $52.34 9/15/20221,690,000 shares $87.39 million +13.4%N/A8 $51.71 8/31/20221,490,000 shares $77.91 million +27.4%N/A7.2 $52.29NYSE Spotlight & A Soaring Biotech Breakthrough You Need to See (Ad)The CEO of a groundbreaking biotech firm we’ve been closely following made headlines with a stunning appearance on the NY Stock Exchange floor, unveiling news that's too big to ignore. But here’s why this matters to you: in the world of investing, timing is everything. Get instant access to our exclusive report RDY Short Interest - Frequently Asked Questions What is Dr. Reddy's Laboratories' current short interest? Short interest is the volume of Dr. Reddy's Laboratories shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 751,000 shares of RDY short. Learn More on Dr. Reddy's Laboratories' current short interest. What is a good short interest ratio for Dr. Reddy's Laboratories? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RDY shares currently have a short interest ratio of 4.0. Learn More on Dr. Reddy's Laboratories's short interest ratio. Is Dr. Reddy's Laboratories' short interest increasing or decreasing? Dr. Reddy's Laboratories saw a increase in short interest in April. As of April 15th, there was short interest totaling 751,000 shares, an increase of 20.0% from the previous total of 625,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Dr. Reddy's Laboratories' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Dr. Reddy's Laboratories: Karuna Therapeutics, Inc. (5.16%), United Therapeutics Co. (9.96%), Sarepta Therapeutics, Inc. (5.15%), BeiGene, Ltd. (1.92%), Viatris Inc. (3.55%), Catalent, Inc. (3.97%), Teva Pharmaceutical Industries Limited (1.04%), Roivant Sciences Ltd. (8.18%), Legend Biotech Co. (6.04%), Ascendis Pharma A/S (6.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Dr. Reddy's Laboratories stock? Short selling RDY is an investing strategy that aims to generate trading profit from Dr. Reddy's Laboratories as its price is falling. RDY shares are trading down $0.95 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dr. Reddy's Laboratories? A short squeeze for Dr. Reddy's Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RDY, which in turn drives the price of the stock up even further. How often is Dr. Reddy's Laboratories' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RDY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Karuna Therapeutics Short Interest United Therapeutics Short Interest Sarepta Therapeutics Short Interest BeiGene Short Interest Viatris Short Interest Catalent Short Interest Teva Pharmaceutical Industries Short Interest Roivant Sciences Short Interest Legend Biotech Short Interest Ascendis Pharma A/S Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:RDY) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersThe Gold Grab of the CenturyColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsTrump’s last act as President Porter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs Tesla going out of business?DTIElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing